Located in The Colony, Texas, GeneIQ’s state-of-the-art molecular diagnostics laboratory provides a multifaceted testing portfolio. It focuses on Pharmacogenomic testing (PGx) and infectious disease testing for respiratory, urinary, and COVID-19 pathogens. The company created a highly efficient, automated lab process with a paperless, web-based system that provides 24-hour turnaround time for results. The company’s testing methodology accurately identifies with 97% sensitivity if the virus is currently present, and with 99.9% specificity if the virus is not.